ReviewHematological oncology2019

Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper.

Antonio Cuneo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.